Pavella Therapeutics Inc. (PVLA) at a glance

Pavella Therapeutics Inc. (PVLA) is a Healthcare company. It trades at $115.61. It does not pay a dividend. Vestovix scores it 52/100 overall. Its strongest dimension is Momentum (67/100) and its weakest is Income (40/100).

Price
$115.61
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$20.20 to $151.18
Vestovix Score52/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
67